SciClone Pharmaceuticals (Holdings) Balance Sheet Health
Financial Health criteria checks 6/6
SciClone Pharmaceuticals (Holdings) has a total shareholder equity of CN¥3.3B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥4.0B and CN¥735.2M respectively. SciClone Pharmaceuticals (Holdings)'s EBIT is CN¥1.2B making its interest coverage ratio -98. It has cash and short-term investments of CN¥2.2B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | -98x |
Cash | CN¥2.22b |
Equity | CN¥3.27b |
Total liabilities | CN¥735.18m |
Total assets | CN¥4.00b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6600's short term assets (CN¥3.4B) exceed its short term liabilities (CN¥698.2M).
Long Term Liabilities: 6600's short term assets (CN¥3.4B) exceed its long term liabilities (CN¥36.9M).
Debt to Equity History and Analysis
Debt Level: 6600 is debt free.
Reducing Debt: 6600 had no debt 5 years ago.
Debt Coverage: 6600 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 6600 has no debt, therefore coverage of interest payments is not a concern.